top of page
PharmXHealthOne logo
PHO.com blue & red colors only logo transp.png
  • Instagram
  • Facebook
  • X
  • LinkedIn
  • YouTube

PHARMXHEALTHONE
MEDICAL WEIGHT LOSS AGREEMENT & TERMS OF SERVICE

Nationwide Telehealth + Local In-Clinic Services

This Medical Weight Loss Agreement (“Agreement”) outlines the terms, conditions, responsibilities, and obligations governing participation in the PharmXHealthOne Medical Weight Loss Program. By enrolling in the program, completing intake forms, or signing below, the Patient (“I,” “me,” or “my”) agrees to the following:

 

1. Program Overview

PharmXHealthOne provides medically supervised weight loss services, which may include:

  • FDA-approved or compounded weight loss medications (including Semaglutide, Tirzepatide, or others)

  • Nutrition, lifestyle, and behavioral counseling

  • Medical monitoring through telehealth or in-person visits

  • Optional peptide, hormone optimization, and functional medicine support

PharmXHealthOne reserves the right to modify program features at any time to maintain clinical safety, legal compliance, and operational integrity.

 

2. Telehealth Eligibility & State Regulations

I understand that PharmXHealthOne delivers services nationwide through licensed telehealth providers. Telehealth prescribing rules differ by state; therefore:

  • Some medications may be restricted or unavailable in certain states

  • Some states require an initial in-person physical exam

  • Compounded medications may be regulated differently in my state

  • PharmXHealthOne must comply with all federal and state medical board requirements

 

I acknowledge that PharmXHealthOne may be unable to prescribe certain treatments depending on my state of residence.

 

3. Medication Disclosure

I understand the following:

 

3.1. FDA-Approved Medications
PharmXHealthOne may prescribe branded FDA-approved medications such as Wegovy, Ozempic, Zepbound, or Mounjaro when medically appropriate and available.

 

3.2. Compounded Medications
If prescribed a compounded formulation of Semaglutide or Tirzepatide, I acknowledge:

  • Compounded medications are not FDA-approved

  • They are prepared by licensed 503A or 503B compounding pharmacies

  • Formulations may differ from branded medications

 

3.3. Provider Discretion
The prescribing provider determines whether an FDA-approved or compounded medication is clinically appropriate.

 

4. Medical Risks & Limitations

I understand that weight loss medications may cause side effects, including but not limited to:

  • Nausea, vomiting, constipation, diarrhea

  • Decreased appetite

  • Headaches, fatigue, or dizziness

  • Abdominal discomfort

  • Injection-site reactions

 

Serious risks may include:

  • Pancreatitis

  • Gallbladder disease

  • Kidney complications

  • Hypoglycemia

  • Potential thyroid risks

 

I agree to immediately report concerning symptoms and may be instructed to discontinue medication.

 

5. Program Responsibilities

I agree to:

  • Follow all medical instructions

  • Attend required follow-up visits

  • Complete required lab testing

  • Disclose full and accurate medical information

  • Not share my medication with others

  • Notify PharmXHealthOne of changes in health status or medication use

 

Non-compliance may result in treatment delay, suspension, or discontinuation.

 

6. Pregnancy, Breastfeeding & Fertility

I understand:

  • Weight loss medications are contraindicated during pregnancy or breastfeeding

  • I must notify my provider immediately if I become pregnant or suspect pregnancy

  • I may be required to stop medication immediately

 

7. Labs, Monitoring & Follow-Up

PharmXHealthOne may require initial and ongoing labs for clinical safety. Failure to complete labs within the requested timeframe may result in:

  • Treatment suspension

  • Medication pauses

  • Program discontinuation

 

I am responsible for the cost of all labs unless otherwise stated.

 

8. No Guarantee of Results

I understand and agree that:

  • PharmXHealthOne does not guarantee any specific amount of weight loss

  • Results vary based on medical, behavioral, lifestyle, and metabolic factors

  • Program success requires adherence to medication and lifestyle recommendations

 

Marketing testimonials or examples are not guarantees of individual outcomes.

 

9. In-Person vs. Nationwide Treatment Availability

I acknowledge:

  • Weight loss medications and telehealth oversight are available nationwide

  • Equipment-based treatments (laser, contouring, etc.) and IV therapies are available only in Florida or within a 20-mile radius of the Boynton Beach clinic

  • Medication prescriptions may be available nationwide but infusions must occur locally

 

10. Medication Fulfillment

Prescription fulfillment may occur through:

  • FDA-authorized pharmacies

  • Licensed compounding pharmacies

  • PharmXHealthOne’s partnered pharmacies

 

I acknowledge that:

  • Pharmacy processing times vary

  • Medication delays are not controlled by PharmXHealthOne

  • Compounded medication fees are non-refundable after the pharmacy begins processing

 

11. Fees, Payments & Refund Policy

I agree to the following financial terms:

  • All program fees, medication costs, follow-up visit charges, and labs are my responsibility

  • Insurance may not cover weight loss services or compounded medications

  • Payments are due at the time of service or at the time of ordering

  • PharmXHealthOne does not guarantee insurance reimbursement

  • Refunds are not issued for medications once they are ordered or processed

 

PharmXHealthOne reserves the right to modify pricing, fees, or program structure.

 

12. Termination of Program Participation

PharmXHealthOne may terminate or suspend my participation for:

  • Safety concerns

  • Non-compliance

  • Failure to complete labs

  • Providing inaccurate medical information

  • Violation of state prescribing regulations

  • Abusive or inappropriate conduct

 

I may voluntarily withdraw at any time, but previously paid fees may not be refundable.

 

13. Privacy, HIPAA & Confidentiality

PharmXHealthOne complies with all applicable federal and state privacy laws, including HIPAA.

I acknowledge that:

  • My medical information will be handled securely

  • Telehealth services may involve digital communication platforms

  • I consent to the use of electronic communication for appointment reminders, treatment updates, and clinical communication

 

14. Telehealth Consent

By enrolling, I provide consent for:

  • Remote diagnosis, evaluation, and treatment

  • Use of electronic communication, video, audio, or messaging

  • Storage of medical records in secure electronic systems

 

Telehealth services have inherent risks, including potential data interruption or unauthorized access. PharmXHealthOne uses HIPAA-compliant systems but cannot guarantee absolute cybersecurity.

 

15. Indemnification

I agree to hold harmless and indemnify PharmXHealthOne, its medical providers, staff, employees, and affiliates from:

  • Claims arising from my failure to follow treatment instructions

  • Misuse or mishandling of prescribed medications

  • Failure to disclose full medical information

  • Non-compliance with required follow-up care

 

16. Acknowledgment & Acceptance

By signing below, I confirm that:

  • I have read and understand this Agreement

  • My questions have been answered

  • I voluntarily agree to participate in the Medical Weight Loss Program

  • I understand the risks, responsibilities, and limitations of treatment

  • I agree to comply with all program requirements

 

PATIENT SIGNATURE

Patient Name: __________________________________

Date of Birth: __________________________________

State of Residence: _______________________________

Signature: _______________________________________

Date: ___________________________________________

PROVIDER SIGNATURE

Provider Name: __________________________________

License Number / State: ____________________________

Signature: _______________________________________

Date: ___________________________________________

WEIGHT LOSS MEDICATION DISCLAIMER (SEMAGLUTIDE & TIRZEPATIDE)

Last updated: July 2, 2025

General Medical Disclaimer
Semaglutide and Tirzepatide are prescription medications used as part of a medically supervised weight-management program. PharmXHealthOne prescribes these medications only after a complete telehealth or in-person consultation, medical review, and determination of medical appropriateness by a licensed provider.
These medications are not suitable for everyone. Eligibility requires completing all intake questions, medical history, documentation, and any required lab work.
 
FDA Status & Compounded Medication Disclaimer
FDA-approved versions of Semaglutide and Tirzepatide (e.g., Wegovy, Ozempic, Zepbound, Mounjaro) may be prescribed when clinically appropriate and available.
 
PharmXHealthOne may also prescribe compounded Semaglutide or compounded Tirzepatide from licensed 503A or 503B compounding pharmacies when FDA-approved products are unavailable or when a prescriber determines compounded alternatives are medically necessary.
 
Compounded medications:

  • Are not FDA-approved products

  • Are prepared by licensed U.S. compounding pharmacies

  • Must comply with state regulations

  • May vary in formulation compared to branded FDA-approved versions

 
Patients will be informed when a prescription is compounded.
 
Risks & Side Effects Disclaimer
Semaglutide and Tirzepatide may cause side effects. Common risks include:

  • Nausea, vomiting, diarrhea, or constipation

  • Decreased appetite

  • Injection-site reactions

  • Fatigue or headache

  • Bloating or mild stomach discomfort

 
Serious but less common risks may include:

  • Pancreatitis

  • Gallbladder disease

  • Kidney issues

  • Hypoglycemia (especially if combined with other glucose-lowering agents)

  • Possible thyroid C-cell tumor risk (observed in rodents; relevance to humans unknown)

 
Patients must immediately report:

  • Severe abdominal pain

  • Signs of dehydration

  • Persistent vomiting

  • Swelling in neck or difficulty breathing

  • Allergic reactions

 
These medications should NOT be used by individuals with:

  • Personal or family history of medullary thyroid carcinoma (MTC)

  • Multiple Endocrine Neoplasia syndrome type 2 (MEN2)

  • Active pancreatitis

 
Pregnancy, Breastfeeding & Fertility Disclaimer
Semaglutide and Tirzepatide are not recommended during pregnancy or while breastfeeding.
Patients must notify the provider immediately if:

  • They become pregnant

  • Are planning pregnancy

  • Suspect pregnancy

 
Female patients of reproductive age may be required to confirm pregnancy status.
 
Lab Testing & Follow-Up Compliance
Providers may require baseline and follow-up laboratory tests, including:

  • A1C

  • Liver function

  • Kidney function

  • Lipid profile

 
Failure to comply with required labs or follow-up visits may result in treatment suspension or discontinuation.
 
No Guarantee of Weight Loss
Every patient responds differently. PharmXHealthOne does not guarantee any specific weight loss results, speed of results, or treatment outcomes. Weight reduction depends on medication response, adherence to the program, nutrition, physical activity, and individual metabolic factors.
 
Results presented in marketing materials are estimates only and not promises.
 
State-Specific Prescribing Restrictions
PharmXHealthOne complies with all federal and state telemedicine prescribing laws. Depending on the patient’s state of residence:
 
The following may apply:

  • Required in-state labs

  • Limitations on prescribing compounded medications

  • Restrictions on telehealth prescribing for certain controlled or non-controlled medications

  • Requirement for initial in-person physical exam (certain states)

 
Examples:
California: Additional documentation of medical necessity may be required for compounded medications.
 
New York: Strict compounding and telehealth prescribing oversight; compounded peptides/medications may have restrictions.
 
Texas: Telehealth prescribing permitted but may require additional follow-up or lab compliance.
 
Alabama: Enhanced telemedicine rules may require more documentation before prescribing.
 
Arkansas: Some medications or compounded formulations may require initial in-person exam unless statutory exemptions apply.
 
Patients will be informed if state laws prevent us from prescribing specific formulations.
 
Insurance Coverage Disclaimer
Semaglutide and Tirzepatide—especially compounded versions—are often not covered by insurance plans.
Patients are responsible for:

  • All program fees

  • Medication costs

  • Follow-up visits

  • Required laboratory tests

 
Drug Interactions & Safety Disclaimer
Patients must disclose:

  • All current medications

  • Over-the-counter supplements

  • Vitamins, peptides, and herbs

  • All medical conditions

 
Failure to provide full medical information may increase treatment risk and may result in PharmXHealthOne declining or discontinuing treatment.
 
PharmXHealthOne Provider Discretion
All prescriptions are issued solely at the discretion of the licensed medical provider.
PharmXHealthOne reserves the right to:

  • Decline prescribing

  • Modify treatment

  • Suspend treatment

  • Require additional labs or documentation

  • Discontinue treatment if safety concerns arise

Completion of a consultation does not guarantee prescription approval.

PHARMXHEALTHONE
MEDICAL WEIGHT LOSS CONSENT & ACKNOWLEDGMENT

Nationwide Telehealth + Local In-Clinic Services

This Medical Weight Loss Consent & Acknowledgment outlines the potential benefits, risks, responsibilities, and limitations associated with participating in a medically supervised weight loss program through PharmXHealthOne. By signing below, I confirm that I have read, understood, and voluntarily agree to the following:

 

1. Purpose of the Program

I understand that the PharmXHealthOne Medical Weight Loss Program is designed to support weight reduction and metabolic health through a combination of:

  • Prescription medications (including Semaglutide, Tirzepatide, or others when medically indicated)

  • Nutrition guidance

  • Lifestyle recommendations

  • Medical monitoring

  • Optional peptide or hormone therapies (if appropriate)

 

I understand that participation does not guarantee weight loss or any specific results.

 

2. Telehealth Services & Scope of Practice

I acknowledge that:

  • My evaluation may be conducted through telehealth or in-person, depending on my location and clinical needs.

  • Telehealth services follow state-specific medical regulations, which may limit what medications can be prescribed in some states.

  • A prescription will only be issued if the provider determines it is safe and medically appropriate.

3. Medication Disclosure (Semaglutide, Tirzepatide, and Others)

I acknowledge that:

  • Some medications may be FDA-approved for weight loss or diabetes, while compounded formulations may not be FDA-approved.

  • Compounded medications are produced by licensed 503A or 503B compounding pharmacies and may differ from branded products.

  • The provider will determine whether an FDA-approved or compounded medication is appropriate based on availability, clinical need, and state law.

 

I understand I will be informed when a prescription is compounded.

 

4. Risks, Side Effects & Contraindications

I understand that weight loss medications may cause side effects, including but not limited to:

Common:

  • Nausea, vomiting, constipation, diarrhea

  • Appetite suppression

  • Abdominal discomfort

  • Headache or fatigue

 

Serious (but less common):

  • Pancreatitis

  • Gallbladder disease

  • Kidney complications

  • Hypoglycemia

  • Allergic reactions

  • Potential thyroid risks (rodent studies; relevance to humans unknown)

 

I agree to notify PharmXHealthOne immediately if serious or unexpected symptoms occur.

 

I affirm that I have disclosed:

  • My complete medical history

  • All medications and supplements

  • Any personal or family history of thyroid cancer, MEN2, or pancreatitis

 

5. Laboratory Testing & Monitoring

I acknowledge the following:

  • Baseline and follow-up laboratory tests may be required.

  • I am responsible for completing labs within the timeframe requested by the provider.

  • Failure to complete required tests may result in treatment delay, suspension, or discontinuation for my safety.

 

6. Pregnancy, Breastfeeding & Fertility

I understand that:

  • Weight loss medications are NOT recommended during pregnancy or breastfeeding.

  • If I become pregnant or suspect pregnancy, I must discontinue medication immediately and notify my provider.

 

7. Contraindications & Provider Discretion

I understand that PharmXHealthOne may decline to prescribe or continue treatment if:

  • I have contraindications

  • I fail to provide accurate medical information

  • I do not comply with required monitoring

  • My health status changes

  • State or federal regulations restrict prescribing

Completion of a consultation does not guarantee medication approval.

 

8. Lifestyle Responsibilities

I understand that weight loss medication is most effective when combined with:

  • A healthy nutrition plan

  • Regular physical activity

  • Hydration and sleep optimization

  • Stress management

Medication does not replace my responsibility for lifestyle changes.

 

9. No Guarantee of Results

I acknowledge that:

  • Individual results vary significantly.

  • Weight loss outcomes depend on numerous factors including adherence, metabolism, medical conditions, and lifestyle.

  • PharmXHealthOne does not guarantee any specific weight loss amount, timeframe, or outcome.

 

10. State-Specific Telehealth & Medication Regulations

I understand that state laws may limit or prohibit:

  • Prescribing compounded medications

  • Prescribing certain medications via telehealth

  • Issuing prescriptions without in-state labs or physical examination

If my state restricts a medication, PharmXHealthOne may not be able to provide it.

 

11. Local vs. Nationwide Treatment Availability

I understand:

  • Weight loss medications and telehealth oversight are available nationwide.

  • IV treatments and equipment-based procedures are available only in Florida (Boynton Beach) or within a 20-mile mobile radius.

 

12. Financial Responsibility

I acknowledge that:

  • Medications and weight loss services may NOT be covered by insurance.

  • I am fully responsible for program fees, medication costs, labs, and follow-up appointments.

  • Payments for compounded medications are non-refundable once processed by the pharmacy.

 

13. Compliance & Communication

I agree to:

  • Take medications exactly as prescribed

  • Attend follow-up visits

  • Report side effects promptly

  • Avoid sharing my medication with others

 

14. Informed Consent

By signing this form:

  • I confirm I have read and understand all information provided.

  • I have had the opportunity to ask questions and they were answered to my satisfaction.

  • I voluntarily agree to participate in the PharmXHealthOne Medical Weight Loss Program.

  • I understand I may withdraw from treatment at any time, but fees already paid may not be refundable.

 

Patient Acknowledgment

Patient Full Name: _______________________________

Date of Birth: _______________________________

State of Residence: _______________________________

Signature: _______________________________________

Date: _______________________________

Provider Name: ___________________________________

Provider Signature: _________________________________

Date: _______________________________

bottom of page